Tagrisso

At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer

AstraZeneca’s Tagrisso and Imfinzi helped patients live longer in separate pivotal clinical trials evaluating the drugs in two different types of lung cancer. The results will be presented Sunday during the annual meeting of the American Society of Clinical Oncology.

By Frank Vinluan

BioPharma, Diagnostics

Guardant scores FDA approval for liquid biopsy test

In a phone interview, Guardant Health CEO Helmy Eltoukhy said he expected the approval to encourage coverage by those payers still on the sidelines.

By Alaric DeArment

At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer

Guardant scores FDA approval for liquid biopsy test

Transforming Patient Care: The Role of AI-Powered Assistants